Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gene, p53”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Testing effectiveness (Phase 2)Study completedNCT00617409
What this trial is testing

To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid

Who this might be right for
Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 69
Not applicableStudy completedNCT01191879
What this trial is testing

A Comparison of p53-induced Genes Activation in Patients With and Without Acute Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Meir Medical Center 79
Testing effectiveness (Phase 2)UnknownNCT02561546
What this trial is testing

P53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma

Who this might be right for
HCCDiabetes
Shenzhen SiBiono GeneTech Co.,Ltd 40
Testing effectiveness (Phase 2)Study completedNCT00049218
What this trial is testing

Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 56
Testing effectiveness (Phase 2)UnknownNCT03544723
What this trial is testing

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Who this might be right for
Solid TumorLymphoma
MultiVir, Inc. 40
Early research (Phase 1)Ended earlyNCT00410865
What this trial is testing

Wild Type p53 Adenovirus for Oral Premalignancies

Who this might be right for
Mouth Cancer
M.D. Anderson Cancer Center 4
Not applicableStudy completedNCT00280761
What this trial is testing

Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation Therapy

Who this might be right for
Colorectal Cancer
UNC Lineberger Comprehensive Cancer Center 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT03611868
What this trial is testing

APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Who this might be right for
Unresectable or Metastatic Melanoma or Advanced Solid TumorsMelanomaUveal Melanoma+5 more
Ascentage Pharma Group Inc. 230
Not applicableStudy completedNCT02289326
What this trial is testing

Biomarker Monitoring in TP53 Mutation Carriers

Who this might be right for
Li-Fraumeni SyndromeHereditary Cancer SyndromesTP53 Gene Germline Mutation Carrier
Scripps Health 6
Testing effectiveness (Phase 2)UnknownNCT02509169
What this trial is testing

Trans-catheter Arterial Embolization Combined With p53 Gene Therapy for Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Shenzhen SiBiono GeneTech Co.,Ltd 60
Testing effectiveness (Phase 2)Ended earlyNCT01670994
What this trial is testing

QUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Altor BioScience 6
Large-scale testing (Phase 3)Study completedNCT00017095
What this trial is testing

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,856
Testing effectiveness (Phase 2)Ended earlyNCT02340156
What this trial is testing

Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma

Who this might be right for
RECURRENT GLIOBLASTOMA
SynerGene Therapeutics, Inc. 1
Testing effectiveness (Phase 2)UnknownNCT02429037
What this trial is testing

P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer

Who this might be right for
Advanced Head and Neck Cancer
Shenzhen SiBiono GeneTech Co.,Ltd 60
Not applicableUnknownNCT02140723
What this trial is testing

P53 and Response to Preoperative Radiotherapy for T2 and T3

Who this might be right for
Rectal Cancer
Medical University of Vienna 60
Post-approval studies (Phase 4)UnknownNCT00894153
What this trial is testing

P53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage

Who this might be right for
Neoplasms
Shenzhen SiBiono GeneTech Co.,Ltd 1,200
Testing effectiveness (Phase 2)Ended earlyNCT03149679
What this trial is testing

The p53 Colorectal Cancer Trial

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer Stage IVTP53 Gene Mutation
Haukeland University Hospital 12
Early research (Phase 1)Study completedNCT00003649
What this trial is testing

Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT00003167
What this trial is testing

Gene Therapy in Treating Patients With Advanced Bladder Cancer

Who this might be right for
Recurrent Bladder CancerStage I Bladder CancerStage II Bladder Cancer+3 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01326871
What this trial is testing

ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer

Who this might be right for
Transitional Cell Carcinoma of BladderUrethra CancerUreter Cancer+1 more
Altor BioScience 68
Next Page